Dear friends, colleagues and partners from the clinical trial community, working in or with Africa,
On behalf of the wonderful ACCT coordination team, as well as the ‘Centre de Recherches Médicales de Lambaréné’ (CERMEL), I respectfully welcome you to the ACCT in Africa, which will take place in Lambaréné, a historic place with a rich legacy emanating both from Gabon and many other countries around the World.
Though Africa still produces less than other regions in terms of scientific output, an active and growing community of clinical trial experts does exist on the African continent.
However, its members along with their work are scattered. Therefore, the challenge of achieving a sustainable impact on the African healthcare system still remains.
ACCT will be a brand-new experience, which we hope will be lasting. The aim is to bring together this research community and all its partners, but especially to create a meeting place for African society as a whole, including ethicists, regulatory bodies, health policy-makers, entrepreneurs and social organizations working on public health issues.
In addition, ACCT aims to help develop a learned society for clinical trials in Africa, and to reinforce a framework for collaboration with international partners.
I would like to finish by saying thank you to our sponsors and international partners TDR/WHO and EDCTP, who financed this first Congress as part of their activities to build clinical research capacity in Africa.
Finally, on behalf of CERMEL, I express my thanks to the Government of the Gabonese Republic for its full support of medical research.